• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CMS Approves Livongo As An Enrolled Provider for Medicare Advantage Members

by Fred Pennic 04/30/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

CMS Approves Livongo As An Enrolled Provider for Medicare Advantage Members

Livongo, the leading Applied Health Signals company announced that it has been approved by the Centers for Medicare and Medicaid Services (CMS) as an enrolled provider for Medicare Advantage members. In addition, starting in June, the Livongo for Diabetes program will be available to Medicare Advantage members of Cambia Health Solutions’ regional health plans.

Empowering America’s Senior Population

Cambia reaches nearly 70 million Americans nationwide, including more than two million people in the Pacific Northwest who are enrolled in regional health plans in Washington, Oregon, Idaho, and Utah. The Livongo solution is currently available to eligible members of Cambia’s regional health plans. Expanded Medicare Advantage partnerships, like with Cambia’s regional health plans, allow Livongo to provide these Members a new experience in how they manage chronic conditions.

Impact of CMS Approval as an Enrolled Medicare Advantage Member

“We are extremely excited to share that Livongo has received CMS approval as an enrolled provider. Completing this process is a significant differentiator for Livongo and represents our commitment to delivering the highest quality services to the Medicare Advantage population” said Livongo Chief Executive Officer Zane Burke. “This is another example of the value of Livongo’s partnership with Cambia as we continue to work together to expand our solutions in a way that is most beneficial to our Members.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Applied Health Signals, Cambia Health Solutions, CMS, diabetes, Livongo Health, medicaid, medicare, Medicare Advantage, WASHINGTON

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |